IQARMYN

Dead / Abandoned — Abandoned — no statement of use filed (as of 06 Nov 2023)

What this means for you

This application is over — abandoned 06 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97267319
Mark type
Stylized text
Filed
15 Feb 2022
Published for opposition
07 Feb 2023
Abandoned
06 Nov 2023
Attorney of record
Aaron Y. Silverstein

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; synthetic peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics; phytotherapy preparations for medical use; diagnostic preparations in vials for medical use; drug delivery agents in the form of filled vials that facilitate the delivery of pharmaceutical preparations; pre-filled syringes for medical and clinical purposes, sold filled with indigo carmine solutions for marking tissue by injection application in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable, for the antiseptic treatment orally or topically, for marking and functional verification gynecological and urological systems, by instillation, injection or local application
  • Class 010 — Medical apparatus: Medical apparatus and instruments for use in exploratory endoscopy procedures in surgery, gynecology, urology, gastroenterology and medical imaging procedures; apparatus and instruments for diagnostic purposes for medical use for use in surgery, gynecology, urology and gastroenterology procedures

Owner

Prosecution history

  • 06 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 06 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
  • 04 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 07 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 07 Feb 2023 — PUBLISHED FOR OPPOSITION
  • 18 Jan 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 30 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 30 Nov 2022 — ASSIGNED TO EXAMINER
  • 18 Feb 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 18 Feb 2022 — NEW APPLICATION ENTERED

View this trademark record on Marksy